Going "social" to access experimental and potentially life-saving treatment: an assessment of the policy and online patient advocacy environment for expanded access.
Mackey, Tim K; Schoenfeld, Virginia J.
; 14: 17, 2016 Feb 02.
Artigo em Inglês | MEDLINE | ID: mdl-26843367
(R)evolution: toward a new paradigm of policy and patient advocacy for expanded access to experimental treatments.
Fairer way to distribute last-ditch drugs gets real-world trial.
Right-to-try laws and individual patient "compassionate use" of experimental oncology medications: A call for improved provider-patient communication.
Stem-cell therapy takes off in Texas.
Stem-cell ruling riles researchers.
21<sup>st</sup> Century Citizen Pharma: The FDA & Patient-Focused Product Development.
Experts critical of America's right-to-try drug laws.
Right-to-Try Investigational Therapies for Incurable Disorders.
Little to lose and no other options: Ethical issues in efforts to facilitate expanded access to investigational drugs.
Improving Expanded Access in the United States: The Role of the Institutional Review Board.